Search
Publication

Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy

READ ON ORCID
Authors
Reis-Mendes A., Gomes A.S., Carvalho R.A., Carvalho F., Remião F., Pinto M., Bastos M.L., Sousa E., Costa V.M.
Date
2017-04-01
Source
Archives of Toxicology
DOI
https://doi.org/10.1007/s00204-016-1839-z
EID
2-s2.0-84987667526